[
  {
    "ts": null,
    "headline": "Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics",
    "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=2caedc74b84ad9fecc73c4dcfbd5409a14af9c2b53c5a59a73955b30b844c848",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753912802,
      "headline": "Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics",
      "id": 136149607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=2caedc74b84ad9fecc73c4dcfbd5409a14af9c2b53c5a59a73955b30b844c848"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Earnings Beat. Diabetes Device Maker Names New CEO.",
    "summary": "Dexcom stock fell late Wednesday as it reported Q2 earnings that topped expectations and named a new chief executive officer.",
    "url": "https://finnhub.io/api/news?id=71a9c18a3e6907f6efeb30d628b3e5f64e047efbf1e2f51701f6e6cc87a933c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753910499,
      "headline": "Dexcom Earnings Beat. Diabetes Device Maker Names New CEO.",
      "id": 136149608,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Dexcom stock fell late Wednesday as it reported Q2 earnings that topped expectations and named a new chief executive officer.",
      "url": "https://finnhub.io/api/news?id=71a9c18a3e6907f6efeb30d628b3e5f64e047efbf1e2f51701f6e6cc87a933c0"
    }
  },
  {
    "ts": null,
    "headline": "DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates",
    "summary": "Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be around $4.61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=3a82facc9b6033003c813869bdf6cf459955306e24a28bbdf90b83ed445cf6e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753910457,
      "headline": "DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates",
      "id": 136149609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be around $4.61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=3a82facc9b6033003c813869bdf6cf459955306e24a28bbdf90b83ed445cf6e6"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (DXCM) Q2 Earnings and Revenues Top Estimates",
    "summary": "DexCom (DXCM) delivered earnings and revenue surprises of +6.67% and +3.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=82a01f30ac6360567db2ef5bb7a5ac14382c127d60ecf3df0984250492bf6b2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753910102,
      "headline": "DexCom (DXCM) Q2 Earnings and Revenues Top Estimates",
      "id": 136149610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom (DXCM) delivered earnings and revenue surprises of +6.67% and +3.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=82a01f30ac6360567db2ef5bb7a5ac14382c127d60ecf3df0984250492bf6b2d"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by DexCom, Inc.",
    "url": "https://finnhub.io/api/news?id=c4334575e6cb2493b52057b6ad85d7f6f8d8d73f449e0f00ccdebf7419eec67a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753909177,
      "headline": "DexCom, Inc. 2025 Q2 - Results - Earnings Call Presentation",
      "id": 136146987,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by DexCom, Inc.",
      "url": "https://finnhub.io/api/news?id=c4334575e6cb2493b52057b6ad85d7f6f8d8d73f449e0f00ccdebf7419eec67a"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript",
    "summary": "DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ETCompany ParticipantsJacob Steven Leach - President &amp; COOJereme M.",
    "url": "https://finnhub.io/api/news?id=4ed7cad72d96e778c234f5842916fa5a58838f9b12a07ad74cf6c659e2068ed5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753909109,
      "headline": "DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript",
      "id": 136146988,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ETCompany ParticipantsJacob Steven Leach - President &amp; COOJereme M.",
      "url": "https://finnhub.io/api/news?id=4ed7cad72d96e778c234f5842916fa5a58838f9b12a07ad74cf6c659e2068ed5"
    }
  },
  {
    "ts": null,
    "headline": "DexCom: Q2 Earnings Snapshot",
    "summary": "SAN DIEGO (AP) — DexCom Inc. DXCM) on Wednesday reported second-quarter net income of $179.8 million. On a per-share basis, the San Diego-based company said it had net income of 45 cents.",
    "url": "https://finnhub.io/api/news?id=e082d08a20d887649d2e7066f38b5789326064436ad32c63ecdac81afd8b8b56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753906272,
      "headline": "DexCom: Q2 Earnings Snapshot",
      "id": 136149611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO (AP) — DexCom Inc. DXCM) on Wednesday reported second-quarter net income of $179.8 million. On a per-share basis, the San Diego-based company said it had net income of 45 cents.",
      "url": "https://finnhub.io/api/news?id=e082d08a20d887649d2e7066f38b5789326064436ad32c63ecdac81afd8b8b56"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan",
    "summary": "SAN DIEGO, July 30, 2025--Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan",
    "url": "https://finnhub.io/api/news?id=d7512d4383ca526c2a4b3d8232bf811ab8477b4c17f66edd50b84003d289732d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753905720,
      "headline": "Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan",
      "id": 136149612,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, July 30, 2025--Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan",
      "url": "https://finnhub.io/api/news?id=d7512d4383ca526c2a4b3d8232bf811ab8477b4c17f66edd50b84003d289732d"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom CEO Kevin Sayer to step down",
    "summary": "Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.",
    "url": "https://finnhub.io/api/news?id=1c6980daef0a81917fdeb39c989218e7c14063cdc52e935a2faa3867a65cf8f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753893889,
      "headline": "Dexcom CEO Kevin Sayer to step down",
      "id": 136149613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.",
      "url": "https://finnhub.io/api/news?id=1c6980daef0a81917fdeb39c989218e7c14063cdc52e935a2faa3867a65cf8f2"
    }
  },
  {
    "ts": null,
    "headline": "Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program",
    "summary": "BURNABY, British Columbia, July 30, 2025--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continuous Glucose Monitoring (CGM) System as part of the Ontario Drug Benefit (ODB) program for eligible Ontarians who manage their diabetes with insulin.*",
    "url": "https://finnhub.io/api/news?id=0de0982afdad8982cf82788f49a0f307ea7f2b7adad706d0691f083992b857c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753876800,
      "headline": "Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program",
      "id": 136130590,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "BURNABY, British Columbia, July 30, 2025--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continuous Glucose Monitoring (CGM) System as part of the Ontario Drug Benefit (ODB) program for eligible Ontarians who manage their diabetes with insulin.*",
      "url": "https://finnhub.io/api/news?id=0de0982afdad8982cf82788f49a0f307ea7f2b7adad706d0691f083992b857c8"
    }
  }
]